Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics

Schizophrenia Research

Volumn 24, Issue 3, 1997, Pages 349-355

  Beasley, Clare L ^a   Reynolds, Gavin P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

GABA; Human brain; Parvalbumin; Prefrontal cortex; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; PARVALBUMIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA;

AGED; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; INTERNEURONS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; NEURONS; PARVALBUMINS; PREFRONTAL CORTEX; SCHIZOPHRENIA;

EID: 0030947083     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(96)00122-3     Document Type: Article

References (38)

1. Akbarian, S., Bunney, W.E. Jr., Potkin, S.G., Wigal, S.B., Hagman, J.O., Sandman, C.A. and Jones, E.G. (1993a) Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiatry 50, 169-177.
2. Akbarian, S., Vinuela. A., Kim, J.J., Potkin, S.G., Bunney, W.E. Jr. and Jones, E.G. (1993b) Distorted distribution of nicotinamide adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiatry 50, 178-187.
3. Akbarian, S., Kim, J.J., Potkin, S.G., Hagman, J.O., Tafazzoli, A., Bunney, W.E. Jr. and Jones, E.G. (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52, 258-266.
4. Benes, F.M., Paskervich, P., Davidson, J. and Domesick, V. (1985) Synaptic re-arrangements in medial prefrontal cortex of haloperidol treated rats. Brain Res., 348, 15-20.
5. Benes, F.M., Davidson, J. and Bird, E.D. (1986) Quantitative cytoarchitectural analyses of the cerebral cortex of schizophrenics. Arch. Gen. Psychiatry 43, 31-35.
6. Benes, F.M. and Bird, E.D. (1987) An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch. Gen. Psychiatry 44, 608-616.
7. Benes, F.M., McSparren, J., Bird, E.D., SanGiovanni, J.P. and Vincent, S.L. (1991) Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry 48, 996-1001.
8. A receptor binding in superficial layers of cingulate cortex in schizophrenics. J. Neurosci. 12, 924-929.
9. Bruton, C.J., Crow, T.J., Frith, C.D., Johnstone, E.C., Owens, D.G.C. and Roberts, G.W. (1990) Schizophrenia and the brain: a prospective clinico-neuropathological study. Psychiatr. Med. 20, 285-304.
10. Conde, F., Lund, J., Jacobowitz, D.M., Baimbridge, K.G. and Lewis D.A. (1994) Local circuit neurons immunoreactive for calretinin, calbindin D-28K or parvalbumin in monkey prefrontal cortex: distribution and morphology. J. Comp. Neurol. 341, 95-116.
11. Conrad, A.J. and Scheibel, A.B. (1987) Schizophrenia and the hippocampus: the embryological hypothesis extended. Schizophr. Bull. 13, 577-587.
12. Daviss, S.R. and Lewis, D.A. (1995) Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res. 59, 81-96.
13. DeFelipe, J., Hendry, S.H.C. and Jones, E.G. (1989) Visualisation of chandelier cell axons by parvalbumin-immunoreactivity in monkey cerebral cortex. Proc. Natl. Acad. Sci. USA 86, 2093-2097.
14. Delalle, I., Uylings, H.B.M., Evers, P. and Kostovic, I. (1993) Development of parvalbumin-immunoreactivity in the human prefrontal cortex. Eur. J. Neurosci., Suppl. ENA 6, 106.
15. Evers, P. and Uylings, H.B.M. (1994) Effects of microwave pretreatment on immunocytochemical staining of vibratome sections and tissue blocks of human cerebral cortex stored in formaldehyde fixative for long periods. J. Neurosci. Meth. 55, 163-172.
16. Falkai, P. and Bogerts, B. (1986) Cell loss in the hippocampus of schizophrenics. Eur. Arch. Psychiatry Neurol. Sci. 236, 154-161.
17. Feighner, J.P., Robin, E., Guze, S.B., Woodruff, R.A., Winoku, G. and Munoz, R. (1972) Diagnostic criteria for use in psychiatric research. Arch. Gen. Psychiatry 26, 57-63.
18. Ferrer, I., Soriano, E., Tunon, T., Fonseca, M. and Guionnet, N. (1991) Parvalbumin-immunoreactive neurons in normal human temporal neocortex and in patients with Alzheimer's disease. J. Neurol. Sci. 106, 135-141.
19. 3H-Muscimol binding sites are increased in autopsied brains of chronic schizophrenics. Life Sci. 40, 259-266.
20. Hendrickson, A.E., Van Brederode, J.F.M., Mulligan, K.A. and Celio, M.R. (1991) Development of the calcium binding proteins parvalbumin and calbindin in monkey striate cortex. J. Comp. Neurol. 307, 626-646.
21. Hendry, S.H.C., Jones, E.G., Emson, P.C., Lawson, D.E.M., Heizmann, C.W. and Streit, P. (1989) Two classes of cortical GABAergic neurons defined by differential calcium binding protein immunoreactivities. Exp. Brain Res. 76, 467-472.
22. Heyes, M., Saito, K., Crowley, J., Davis, L.E., Demitrack, M.A., Der, M., Dilling, L.A., Elia, J., Kruesi, M.J.P., Lackner, A., Larsen, S.A., Lee, K., Leonard, H.L., Markey, S.P., Martin, A., Milstein, S., Mouradian, M.M., Pranzatelli, M.R., Quearry, B.J., Salazar, A., Smith, M., Strauss, S.E., Sunderland, T., Swedo, S.W. and Tourtellotte, W.W. (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115, 1249-1273.
23. Hsu, S.M., Raine, L. and Fanger, H. (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem. 29, 577-580.
24. Jakob, H. and Beckmann, H. (1986) Prenatal developmental disturbances in limbic allocortex of schizophrenics. J. Neural. Transm. 65, 303-326.
25. McNeil, T. (1987) Perinatal influences in the development of schizophrenia. In: Helmchen, H. and Henn, F.A. (Eds.), Biological Perspectives of Schizophrenia. Wiley, Chichester, pp. 125-138.
26. Nitsch, C., Scotti, A.L., Sommacal, A. and Kalt, G. (1989) GABAergic hippocampal neurons resistant to ischaemia-induced delayed neuronal death contain the calcium-binding protein parvalbumin. Neurosci. Lett. 105, 263-268.
27. O'Callaghan, E., Sham, P., Takei, N., Glover, G. and Murray, R.M. (1991) Schizophrenia after prenatal exposure to the 1957 A2 influenza epidemic. Lancet 337, 1248.
28. 3H] MK801 binding to the NMDAR complex and its modulation in human frontal cortex during development and ageing. Brain Res. 588, 277-286.
29. Roberts, G.W., Ferrier, N.I., Lee, Y., Crow, T.J., Johnstone, E.C., Owens, D.G.C., Bacharese-Hamilton, A.J., McGregor, G., O'Shaughnessy, D., Polak, J.M. and Bloom, S.R. (1983) Peptides, the limbic lobe and schizophrenia. Brain Res. 288, 199-211.
30. Roberts, G.W., Colter, N., Lofthouse, R., Bogerts, B., Zech, M. and Crow, T.J. (1986) Gliosis in schizophrenia: a survey. Biol. Psychiatry 21, 1043-1050.
31. Satoh, J., Tabira, T., Sano, M., Nakayama, H. and Tateishi, J. (1991) Parvalbumin-immunoreactive neurons in the human central nervous system are decreased in Alzheimer's disease. Acta Neuropathol. 81, 388-395.
32. Selemon, L.D., Rajkowska, G. and Goldman-Rakic, P.S. (1995) Abnormally high neuronal density in the schizophrenic cortex. Arch. Gen. Psychiatry 52, 805-828.
33. Solbach, S. and Celio, M.R. (1991) Ontogeny of the calcium binding protein parvalbumin in the rat nervous system. Anat. Embryol. 184, 103-124.
34. Somogyi, D., Hodgson, A.J., Smith, A.D., Nunzi, M.G., Gorio, A. and Wu, J.Y. (1984) Different populations in the visual cortex and hippocampus contain somatostatin-or cholecystokinin-immunoreactive material. J. Neurosci. 4, 2590-2603.
35. Waddington, J.L. (1993) Schizophrenia: developmental neuroscience and pathobiology. Lancet 341, 531-536.
36. Weinberger D.R. (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44, 660-669.
37. Wing, J.K., Cooper, J.E. and Sartorius, N. (1974) The Measurement and Classification of Psychiatric Symptoms. Instruction Manual for the PSE and Catego Program. Cambridge University press, London.
38. Yan, Y.H., Van Brederode, J.F.M. and Hendrickson, A.E. (1995) Developmental changes in calretinin expression in GABAergic and nonGABAergic neurons in monkey striate cortex. J. Comp. Neurol. 363, 78-92.